Literature DB >> 9620074

Multifocal rod electroretinograms.

D C Hood1, E J Wladis, S Shady, K Holopigian, J Li, W Seiple.   

Abstract

PURPOSE: To assess the feasibility of obtaining reliable multifocal rod electroretinograms (ERGS) and to compare them to full-field ERGs.
METHODS: Multifocal rod ERGs were recorded using a stimulus array of 61 hexagons. The minimum number of dark, blank frames between flashes was varied from 0 (a minimum of 13.3 msec between flashes) to 21 (a minimum of 293 msec between flashes). Full-field ERGs were obtained using trains of flashes designed to simulate the multifocal sequences. Flashes were blue (W47B), except in a few cases in which red (W26) was used to check for cone intrusion. Flash intensities varied from -1 to 1.7 log scot td-s.
RESULTS: Dark-adapted, multifocal ERGs to blue flashes had a small, early component followed by a larger, late component. The early component showed little change in amplitude with increasing intensity. Comparisons with the full-field ERGs indicated that the early component was the focal response. The larger, late component was the response to stray light, and it can be suppressed with the addition of a surround. The focal response was from a relatively circumscribed retinal region. This is shown by comparing the multifocal rod responses from a patient with retinitis pigmentosa to her behaviorally measured rod visual field.
CONCLUSIONS: By choosing conditions (namely, flashes of moderate intensity with a surround) to minimize the effects of stray light, multifocal rod ERGs can be recorded with sufficient localization to be clinically useful. However, the signal-to-noise ratio of these multifocal rod ERGs was poorer than for multifocal cone responses for comparable recording periods because of the need for blank frames and the slower recovery of the rods to successive presentations.

Entities:  

Mesh:

Year:  1998        PMID: 9620074

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  8 in total

1.  A comparison of CRT and digital stimulus delivery methods in the multifocal ERG.

Authors:  D Keating; S Parks; C Malloch; A Evans
Journal:  Doc Ophthalmol       Date:  2001-03       Impact factor: 2.379

Review 2.  The electroretinogram: a useful tool for evaluating age-related macular disease?

Authors:  Emma J Berrow; Hannah E Bartlett; Frank Eperjesi; Jonathan M Gibson
Journal:  Doc Ophthalmol       Date:  2010-03-16       Impact factor: 2.379

3.  The local cone and rod system function in early age-related macular degeneration.

Authors:  Changzheng Chen; Lezheng Wu; Dezheng Wu; Shizhou Huang; Feng Wen; Guangwei Luo; Shixian Long
Journal:  Doc Ophthalmol       Date:  2004-07       Impact factor: 2.379

4.  Dynamics of retinal function after multiple photodynamic therapies in age-related macular degeneration: a report of cases.

Authors:  Beatrix Feigl; Brian Brown; Jan Lovie-Kitchin; Lawrence Lee
Journal:  Doc Ophthalmol       Date:  2006-03-06       Impact factor: 2.379

5.  Multimodal assessment of microscopic morphology and retinal function in patients with geographic atrophy.

Authors:  Athanasios Panorgias; Robert J Zawadzki; Arlie G Capps; Allan A Hunter; Lawrence S Morse; John S Werner
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-06-26       Impact factor: 4.799

6.  Relationships among multifocal electroretinogram amplitude, visual field sensitivity, and SD-OCT receptor layer thicknesses in patients with retinitis pigmentosa.

Authors:  Yuquan Wen; Martin Klein; Donald C Hood; David G Birch
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-02-21       Impact factor: 4.799

7.  A comparison of multifocal ERG and frequency domain OCT changes in patients with abnormalities of the retina.

Authors:  Elizabeth A Dale; Donald C Hood; Vivienne C Greenstein; Jeffrey G Odel
Journal:  Doc Ophthalmol       Date:  2009-12-31       Impact factor: 2.379

8.  Senescent Changes and Topography of the Dark-Adapted Multifocal Electroretinogram.

Authors:  Athanasios Panorgias; Megan Tillman; Erich E Sutter; Ala Moshiri; Christina Gerth-Kahlert; John S Werner
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-02-01       Impact factor: 4.799

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.